Literature DB >> 35320687

Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.

Angus D Cowan1, Alessio Ciulli1.   

Abstract

Methods to direct the degradation of protein targets with proximity-inducing molecules that coopt the cellular degradation machinery are advancing in leaps and bounds, and diverse modalities are emerging. The most used and well-studied approach is to hijack E3 ligases of the ubiquitin-proteasome system. E3 ligases use specific molecular recognition to determine which proteins in the cell are ubiquitinated and degraded. This review focuses on the structural determinants of E3 ligase recruitment of natural substrates and neo-substrates obtained through monovalent molecular glues and bivalent proteolysis-targeting chimeras. We use structures to illustrate the different types of substrate recognition and assess the basis for neo-protein-protein interactions in ternary complex structures. The emerging structural and mechanistic complexity is reflective of the diverse physiological roles of protein ubiquitination. This molecular insight is also guiding the application of structure-based design approaches to the development of new and existing degraders as chemical tools and therapeutics.

Entities:  

Keywords:  E3 ligase; PROTAC; molecular glue; targeted protein degradation; ubiquitin–proteasome system

Mesh:

Substances:

Year:  2022        PMID: 35320687     DOI: 10.1146/annurev-biochem-032620-104421

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   27.258


  3 in total

1.  Cullin-independent recognition of HHARI substrates by a dynamic RBR catalytic domain.

Authors:  Katherine H Reiter; Alex Zelter; Maria K Janowska; Michael Riffle; Nicholas Shulman; Brendan X MacLean; Kaipo Tamura; Matthew C Chambers; Michael J MacCoss; Trisha N Davis; Miklos Guttman; Peter S Brzovic; Rachel E Klevit
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

Review 2.  Small molecule inhibitors targeting the cancers.

Authors:  Gui-Hong Liu; Tao Chen; Xin Zhang; Xue-Lei Ma; Hua-Shan Shi
Journal:  MedComm (2020)       Date:  2022-10-13

3.  Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry.

Authors:  Tom Dixon; Derek MacPherson; Barmak Mostofian; Taras Dauzhenka; Samuel Lotz; Dwight McGee; Sharon Shechter; Utsab R Shrestha; Rafal Wiewiora; Zachary A McDargh; Fen Pei; Rajat Pal; João V Ribeiro; Tanner Wilkerson; Vipin Sachdeva; Ning Gao; Shourya Jain; Samuel Sparks; Yunxing Li; Alexander Vinitsky; Xin Zhang; Asghar M Razavi; István Kolossváry; Jason Imbriglio; Artem Evdokimov; Louise Bergeron; Wenchang Zhou; Jagat Adhikari; Benjamin Ruprecht; Alex Dickson; Huafeng Xu; Woody Sherman; Jesus A Izaguirre
Journal:  Nat Commun       Date:  2022-10-06       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.